Biodesix (BDSX) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $23.66, -4.25% vs the prior close of $24.71.
- Volume 79.57K shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
BDSX slides 4.2% to $23.66, a 1-month low. Closed at $23.66, -4.25% vs the prior close of $24.71. Day range $22.60–$24.79, opened at $24.79.
BDSX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — BDSX slides 4.2% to $23.66, a 1-month low
- Closed at $23.66, -4.25% vs the prior close of $24.71. Day range $22.60–$24.79, opened at $24.79.
- Volume was 79.57K shares, 0.7x its 50-day average of 110.97K.
- Price is -11.2% vs its 50-day average ($26.65) and +32.4% vs its 200-day average ($17.86).
- 52-week range $5.26–$31.97; today's close sits at 69% of that range, 26.0% below the 52-week high.
Oct 15, 2026 — BDSX jumps 3.0% to $24.71
- Closed at $24.71, +3.00% vs the prior close of $23.99. Day range $23.84–$24.77, opened at $23.92.
- Volume was 35.20K shares, 0.3x its 50-day average of 111.13K — lighter than usual.
- Price is -7.2% vs its 50-day average ($26.62) and +39.0% vs its 200-day average ($17.78).
- 52-week range $5.26–$31.97; today's close sits at 73% of that range, 22.7% below the 52-week high.
Oct 14, 2026 — BDSX slides 4.0% to $23.99, a 1-month low, 3 down days in a row
- Closed at $23.99, -4.04% vs the prior close of $25.00. Day range $23.65–$25.08, opened at $24.92.
- Volume was 80.90K shares, 0.7x its 50-day average of 110.66K.
- Price is -9.7% vs its 50-day average ($26.58) and +35.6% vs its 200-day average ($17.69).
- 52-week range $5.26–$31.97; today's close sits at 70% of that range, 25.0% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — BDSX dips 2.7% to $25.00, a 1-month low
- Closed at $25.00, -2.72% vs the prior close of $25.70. Day range $24.80–$25.79, opened at $25.79.
- Volume was 53.30K shares, 0.5x its 50-day average of 111.31K — lighter than usual.
- Price is -5.9% vs its 50-day average ($26.55) and +42.0% vs its 200-day average ($17.60).
- 52-week range $5.26–$31.97; today's close sits at 74% of that range, 21.8% below the 52-week high.
Oct 12, 2026 — BDSX dips 1.2% to $25.70
- Closed at $25.70, -1.23% vs the prior close of $26.02. Day range $25.19–$26.62, opened at $26.02.
- Volume was 41.00K shares, 0.4x its 50-day average of 111.33K — lighter than usual.
- Price is -3.0% vs its 50-day average ($26.49) and +46.7% vs its 200-day average ($17.51).
- 52-week range $5.26–$31.97; today's close sits at 77% of that range, 19.6% below the 52-week high.
Oct 9, 2026 — BDSX rises 1.5% to $26.02
- Closed at $26.02, +1.52% vs the prior close of $25.63. Day range $25.63–$26.64, opened at $25.68.
- Volume was 46.70K shares, 0.4x its 50-day average of 111.30K — lighter than usual.
- Price is -1.5% vs its 50-day average ($26.40) and +49.4% vs its 200-day average ($17.42).
- 52-week range $5.26–$31.97; today's close sits at 78% of that range, 18.6% below the 52-week high.
Oct 8, 2026 — BDSX dips 3.0% to $25.63, a 1-month low, 3 down days in a row
- Closed at $25.63, -2.99% vs the prior close of $26.42. Day range $25.10–$26.50, opened at $26.24.
- Volume was 96.00K shares, 0.9x its 50-day average of 110.20K.
- Price is -2.6% vs its 50-day average ($26.31) and +48.0% vs its 200-day average ($17.32).
- 52-week range $5.26–$31.97; today's close sits at 76% of that range, 19.8% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — BDSX slides 5.5% to $26.42
- Closed at $26.42, -5.51% vs the prior close of $27.96. Day range $26.07–$27.78, opened at $27.50.
- Volume was 57.60K shares, 0.5x its 50-day average of 110.43K — lighter than usual.
- Price is +0.8% vs its 50-day average ($26.21) and +53.4% vs its 200-day average ($17.23).
- 52-week range $5.26–$31.97; today's close sits at 79% of that range, 17.4% below the 52-week high.
Oct 6, 2026 — BDSX slides 3.8% to $27.96
- Closed at $27.96, -3.79% vs the prior close of $29.06. Day range $27.52–$29.99, opened at $29.30.
- Volume was 102.20K shares, 0.9x its 50-day average of 109.90K.
- Price is +7.1% vs its 50-day average ($26.10) and +63.2% vs its 200-day average ($17.13).
- 52-week range $5.26–$31.97; today's close sits at 85% of that range, 12.5% below the 52-week high.
Oct 5, 2026 — BDSX jumps 4.8% to $29.06
- Closed at $29.06, +4.83% vs the prior close of $27.72. Day range $26.53–$30.00, opened at $27.72.
- Volume was 181.20K shares, 1.7x its 50-day average of 108.09K.
- Price is +11.8% vs its 50-day average ($25.98) and +70.6% vs its 200-day average ($17.03).
- 52-week range $5.26–$31.97; today's close sits at 89% of that range, 9.1% below the 52-week high.
Oct 2, 2026 — BDSX rises 1.4% to $27.72
- Closed at $27.72, +1.43% vs the prior close of $27.33. Day range $26.97–$28.72, opened at $27.55.
- Volume was 124.30K shares, 1.2x its 50-day average of 106.39K.
- Price is +7.3% vs its 50-day average ($25.84) and +63.8% vs its 200-day average ($16.92).
- 52-week range $5.26–$31.97; today's close sits at 84% of that range, 13.3% below the 52-week high.
BDSX latest news & SEC filings
Every SEC filing by or about BDSX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Patience John converted options/RSUs into 1,360 shares on Sep 30, 2026; now holds 26,743
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Schuler Jack W bought 15,000 shares at $24.47 (≈$367.05K) on Aug 12, 2026
- Schuler Jack W bought 15,000 shares at $24.47 (≈$367.05K) on Aug 12, 2026
- Schuler Jack W bought 15,000 shares at $24.47 (≈$367.05K) on Aug 12, 2026
- Schuler Jack W bought 15,000 shares at $24.47 (≈$367.05K) on Aug 12, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 12, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Schuler Jack W bought 13,700 shares at $24.01 (≈$328.94K) on Aug 11, 2026
- Schuler Jack W bought 13,700 shares at $24.01 (≈$328.94K) on Aug 11, 2026
- Schuler Jack W bought 13,700 shares at $24.01 (≈$328.94K) on Aug 11, 2026
- Schuler Jack W bought 13,700 shares at $24.01 (≈$328.94K) on Aug 11, 2026
- Schuler Jack W bought 13,900 shares at $24.25 (≈$337.07K) on Aug 10, 2026
- Schuler Jack W bought 13,900 shares at $24.25 (≈$337.07K) on Aug 10, 2026
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 5, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $26.86M (prior year $20.02M) (+34.2% vs Jun 30, 2025)
- Net income: -$7.27M (prior year -$11.47M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.71 (prior year -$1.56) (loss narrowed vs Jun 30, 2025)
Aug 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade BDSX
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 4, 2026, Feb 26, 2026, Nov 3, 2025. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.19% (largest 8.4%). That is a volatile stock.
- Liquidity: about 102.63K shares (≈$2.43M) trade per day on average.
- 52-week position: $23.66 vs a range of $5.26–$31.97 (69% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:20 on Sep 15, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 12 open-market buys, 13 sales; latest: Jack W Schuler bought 15,000 shares on Aug 12, 2026.
- Latest filings: 10-Q Aug 5, 2026; 8-K Aug 5, 2026; 8-K May 20, 2026.
- Share count: 10.55M shares outstanding (Jul 30, 2026), -92.8% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Services-Medical Laboratories.
BDSX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 24.79 | 24.79 | 22.60 | 23.66 | 79.57K |
| Oct 15, 2026 | 23.92 | 24.77 | 23.84 | 24.71 | 35.20K |
| Oct 14, 2026 | 24.92 | 25.08 | 23.65 | 23.99 | 80.90K |
| Oct 13, 2026 | 25.79 | 25.79 | 24.80 | 25.00 | 53.30K |
| Oct 12, 2026 | 26.02 | 26.62 | 25.19 | 25.70 | 41.00K |
| Oct 9, 2026 | 25.68 | 26.64 | 25.63 | 26.02 | 46.70K |
| Oct 8, 2026 | 26.24 | 26.50 | 25.10 | 25.63 | 96.00K |
| Oct 7, 2026 | 27.50 | 27.78 | 26.07 | 26.42 | 57.60K |
| Oct 6, 2026 | 29.30 | 29.99 | 27.52 | 27.96 | 102.20K |
| Oct 5, 2026 | 27.72 | 30.00 | 26.53 | 29.06 | 181.20K |
| Oct 2, 2026 | 27.55 | 28.72 | 26.97 | 27.72 | 124.30K |
| Oct 1, 2026 | 29.45 | 29.70 | 26.33 | 27.33 | 178.90K |
| Sep 30, 2026 | 29.15 | 30.13 | 28.14 | 29.83 | 161.30K |
| Sep 29, 2026 | 30.57 | 31.21 | 28.56 | 29.14 | 142.60K |
| Sep 28, 2026 | 29.00 | 31.97 | 28.50 | 30.42 | 204.70K |
| Sep 25, 2026 | 29.47 | 30.17 | 28.48 | 29.10 | 98.30K |
| Sep 24, 2026 | 29.22 | 31.35 | 28.81 | 29.40 | 120.50K |
| Sep 23, 2026 | 27.99 | 29.49 | 27.65 | 29.29 | 69.00K |
| Sep 22, 2026 | 28.37 | 29.07 | 27.75 | 28.15 | 57.00K |
| Sep 21, 2026 | 29.36 | 29.99 | 27.56 | 28.43 | 122.40K |
About Biodesix
Biodesix (BDSX) is listed on the Nasdaq and classified by the SEC under “Services-Medical Laboratories”. Its business address is in LOUISVILLE, CO. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1439725.
BDSX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jean M. Franchi | Director | Jan 6, 2026 |
| Scott Hutton | President & CEO | Feb 23, 2026 |
| Jon Faiz Kayyem | Director | Jan 6, 2026 |
| Lawrence T. Jr Kennedy | Director | Jan 6, 2026 |
| Hany Massarany | Director | Jan 6, 2026 |
| John Patience | Chairman | Jul 2, 2026 |
| Matthew Strobeck | Director | Jan 6, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Robin Harper Cowie | CFO, Sec'y & Treasurer | Feb 23, 2026 |
| Scott Hutton | President & CEO | Feb 23, 2026 |
| Kieran O'Kane | Chief Commercial Officer | Feb 23, 2026 |
| Gary Anthony Pestano | Chief Development Officer | Feb 23, 2026 |
| Chris Vazquez | Chief Accounting Officer | Feb 23, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 12, 2026 | Jack W Schuler | Buy | 15,000 | $24.47 |
| Aug 12, 2026 | Jack W Schuler | Buy | 15,000 | $24.47 |
| Aug 12, 2026 | Jack W Schuler | Buy | 15,000 | $24.47 |
| Aug 12, 2026 | Jack W Schuler | Buy | 15,000 | $24.47 |
| Aug 11, 2026 | Jack W Schuler | Buy | 13,700 | $24.01 |
| Aug 11, 2026 | Jack W Schuler | Buy | 13,700 | $24.01 |
| Aug 11, 2026 | Jack W Schuler | Buy | 13,700 | $24.01 |
| Aug 11, 2026 | Jack W Schuler | Buy | 13,700 | $24.01 |
| Aug 10, 2026 | Jack W Schuler | Buy | 13,900 | $24.25 |
| Aug 10, 2026 | Jack W Schuler | Buy | 13,900 | $24.25 |
| Aug 10, 2026 | Jack W Schuler | Buy | 13,900 | $24.25 |
| Aug 10, 2026 | Jack W Schuler | Buy | 13,900 | $24.25 |
| Feb 23, 2026 | Robin Harper Cowie | Sale | 535 | $12.78 |
| Feb 23, 2026 | Robin Harper Cowie | Sale | 535 | $12.78 |
| Feb 23, 2026 | Robin Harper Cowie | Sale | 535 | $12.78 |
BDSX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $88.50M | $-35.27M | -4.67 | $-23.27M |
| Dec 31, 2024 | $71.32M | $-42.93M | -6.64 | $-48.65M |
| Dec 31, 2023 | $49.09M | $-52.15M | -0.64 | $-22.87M |
| Dec 31, 2022 | $38.21M | $-65.45M | -1.55 | $-44.97M |
| Dec 31, 2021 | $54.51M | $-43.16M | -1.58 | $-28.22M |
Latest balance sheet: total assets $95.33M, total liabilities $86.18M, cash $30.00M (as of Jun 30, 2026).
BDSX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $22.78 |
| May 4, 2026 | 8-K Item 2.02 (results) | $11.27 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $14.22 |
| Nov 3, 2025 | 8-K Item 2.02 (results) | $6.34 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $8.94 |
| May 13, 2025 | 8-K Item 2.02 (results) | $7.18 |
| Mar 3, 2025 | 8-K Item 2.02 (results) | $14.26 |
| Jan 10, 2025 | 8-K Item 2.02 (results) | $25.40 |
| Nov 1, 2024 | 8-K Item 2.02 (results) | $26.00 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 8, 2024 | 8-K Item 2.02 (results) | — |
| Mar 1, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Medical Laboratories
Natera (NTRA)Guardant Health (GH)Quest Diagnostics (DGX)Labcorp (LH)Grail (GRAL)Caris Life Sciences (CAI)Celcuity (CELC)CareDx (CDNA)Veracyte (VCYT)BillionToOne (BLLN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on BDSX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.